BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26277885)

  • 1. Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy.
    Girard A; Jouneau S; Chabanne C; Khouatra C; Lannes M; Traclet J; Turquier S; Delaval P; Cordier JF; Cottin V
    Respiration; 2015; 90(3):220-8. PubMed ID: 26277885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial.
    Vitulo P; Stanziola A; Confalonieri M; Libertucci D; Oggionni T; Rottoli P; Paciocco G; Tuzzolino F; Martino L; Beretta M; Callari A; Amaducci A; Badagliacca R; Poscia R; Meloni F; Refini RM; Geri P; Baldi S; Ghio S; D'Alto M; Argiento P; Sofia M; Guardamagna M; Pezzuto B; Vizza CD
    J Heart Lung Transplant; 2017 Feb; 36(2):166-174. PubMed ID: 27329400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil improves hemodynamic parameters in COPD--an investigation of six patients.
    Alp S; Skrygan M; Schmidt WE; Bastian A
    Pulm Pharmacol Ther; 2006; 19(6):386-90. PubMed ID: 16291503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA
    Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.
    Andersen KH; Iversen M; Kjaergaard J; Mortensen J; Nielsen-Kudsk JE; Bendstrup E; Videbaek R; Carlsen J
    J Heart Lung Transplant; 2012 Apr; 31(4):373-80. PubMed ID: 22226804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of vasodilator therapy in pulmonary hypertension due to COPD: a retrospective analysis.
    Fossati L; Müller-Mottet S; Hasler E; Speich R; Bloch KE; Huber LC; Ulrich Somaini S
    Lung; 2014 Dec; 192(6):987-95. PubMed ID: 25348430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease.
    Carlsen J; Hasseriis Andersen K; Boesgaard S; Iversen M; Steinbrüchel D; Bøgelund Andersen C
    J Heart Lung Transplant; 2013 Mar; 32(3):347-54. PubMed ID: 23265910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.
    Portillo K; Torralba Y; Blanco I; Burgos F; Rodriguez-Roisin R; Rios J; Roca J; Barberà JA
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1313-20. PubMed ID: 26203238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained improvement of clinical status and pulmonary hypertension in patients with severe heart failure treated with sildenafil.
    Urbanowicz T; Straburzyńska-Migaj E; Katyńska I; Araszkiewicz A; Oko-Sarnowska Z; Grajek S; Jemielity M
    Ann Transplant; 2014 Jul; 19():325-30. PubMed ID: 25007352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.
    Benza RL; Rayburn BK; Tallaj JA; Coffey CS; Pinderski LJ; Pamoukian SV; Bourge RC
    Chest; 2006 Apr; 129(4):1009-15. PubMed ID: 16608951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role of CT Metrics in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension.
    Ando K; Kuraishi H; Nagaoka T; Tsutsumi T; Hoshika Y; Kimura T; Ienaga H; Morio Y; Takahashi K
    Lung; 2015 Dec; 193(6):911-8. PubMed ID: 26453478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil in heart transplant candidates with pulmonary hypertension.
    de Groote P; El Asri C; Fertin M; Goéminne C; Vincentelli A; Robin E; Duva-Pentiah A; Lamblin N
    Arch Cardiovasc Dis; 2015; 108(6-7):375-84. PubMed ID: 25921840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
    Chapman TH; Wilde M; Sheth A; Madden BP
    Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP; Sheth A; Wilde M; Ong YE
    Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Udenafil improves exercise capacity in patients with chronic obstructive pulmonary disease: a prospective study.
    Park JS; Lim HJ; Cho YJ; Lee JH; Yoon HI; Lee CT
    COPD; 2012 Aug; 9(5):499-504. PubMed ID: 22946546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.